Cardinal Health, Inc.

Cardinal Health, Inc.(CAH)股票分析

$247.740

+8.299 (+3.35%)收盘时

Loading chart…
最高
247.930
开盘
240.900
成交量加权均价
245.48
成交量
1.97M
市值
24.26B
最低
240.760
成交额
484.31M
企业价值/息税折旧摊销前利润(TTM)
12.88

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

AI 分析 of Cardinal Health, Inc. (CAH)

买入

Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.

分析师评级(16)

-9.11% 下跌空间
持有
1 买入
15 持有
0 卖出
当前: 247.74
最低
209.00
平均
225.18
最高
244.00

RBC Capital

2026-08-19

目标价

$276

跑赢大盘

TD Cowen

2026-08-13

目标价

$280

买入

JPMorgan

2026-08-13

目标价

$260

中性

Barclays

2026-08-13

目标价

$275

增持

Morgan Stanley

2026-08-12

目标价

$265

增持

估值指标

Cardinal Health, Inc.(CAH)当前预期市盈率为 17.70,5 年平均预期市盈率为 14.28。

预期市盈率

高估
5 年均值 P/E
14.28
当前P/E
17.70
高估
17.21
低估
11.36

预期 EV/EBITDA

高估
5 年均值 EV/EBITDA
9.71
当前EV/EBITDA
12.88
高估
11.94
低估
7.49

预期市销率

严重高估
5 年均值 P/S
0.12
当前P/S
0.20
高估
0.16
低估
0.09

Alphio AI 对 CAH 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CAH

$146.16

情景价格

基

基准

基准 · 50%CAH

$128.79

情景价格

悲

悲观

悲观 · 25%CAH

$107.97

情景价格

持有 CAH 的大户

M

Martingale Asset Management, L.P.

+ 持有CAH

+7.91%

3个月收益率

O

Osmosis Investment Management UK Limited

+ 持有CAH

+7.38%

3个月收益率

O

Osaic Advisory Services, LLC

+ 持有CAH

+7.33%

3个月收益率

N

Numeric Investors LLC

+ 持有CAH

+7.32%

3个月收益率

V

Voleon Capital Management LP

+ 持有CAH

+7.07%

3个月收益率

K

Kepler Cheuvreux SA

+ 持有CAH

+6.63%

3个月收益率

事件时间线

2026-10-01 (ET)

16:30:00

Major Averages Little Changed as Micron Reports Strong Q4 Earnings

12:00:00

Major Averages Decline as Treasury Yields Rise

07:00:00

Cardinal Health Extends Agreement with CVS Health to June 30, 2032

07:00:00

Cardinal Health Reaffirms FY 2027 EPS Guidance

2026-08-12 (ET)

08:30:00

Keurig Dr Pepper Appoints Aaron Alt as Director

资讯

CAH 常见问题 —— 由 Alphio AI 解答

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).

Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.

16 analysts cover CAH: 1 rate it Buy, 15 Hold and 0 Sell. The average price target is 225.18.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易